AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionGlen Eagle Advisors, LLC
Latest Disclosed Ownership21,237 shares
Latest Disclosed Value $ 4,618,867
Glen Eagle Advisors, LLC reports 0.58% increase in ownership of 4AB / AbbVie Inc.

On May 15, 2026 - Glen Eagle Advisors, LLC filed a 13F-HR form disclosing ownership of 21,237 shares of AbbVie Inc. (BG:4AB) valued at $4,618,867 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 21,115 shares of AbbVie Inc.. This represents a change in shares of 0.58% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ABBVIE COM 00287Y109 21,237 122 0.58 4,619 -4.27 0.6470
2026-02-13 2025-12-31 13F ABBVIE COM 00287Y109 21,115 2,173 11.47 4,825 10.01 0.6568
2025-11-14 2025-09-30 13F ABBVIE COM 00287Y109 18,942 -125 -0.66 4,386 23.91 0.6096
2025-08-14 2025-06-30 13F ABBVIE COM 00287Y109 19,067 -211 -1.09 3,539 -12.38 0.5444
2025-05-15 2025-03-31 13F ABBVIE COM 00287Y109 19,278 171 0.89 4,039 18.97 0.6686
2025-02-18 2024-12-31 13F ABBVIE COM 00287Y109 19,107 830 4.54 3,395 -5.93 0.5632
2024-11-15 2024-09-30 13F ABBVIE COM 00287Y109 18,277 470 2.64 3,609 18.17 0.6091
2024-08-14 2024-06-30 13F ABBVIE COM 00287Y109 17,807 716 4.19 3,054 -1.86 0.5592
2024-07-03 2024-03-31 13F ABBVIE COM 00287Y109 17,091 -455 -2.59 3,112 14.45 0.5903
2024-08-13 2023-12-31 13F ABBVIE COM 00287Y109 17,546 -165 -0.93 2,719 2.99 0.5650
2024-08-13 2023-09-30 13F ABBVIE COM 00287Y109 17,711 440 2.55 2,640 13.50 0.6122
2024-08-13 2023-06-30 13F ABBVIE COM 00287Y109 17,271 762 4.62 2,327 -11.59 0.5363
2024-08-13 2023-03-31 13F ABBVIE COM 00287Y109 16,509 568 3.56 2,631 2.14 0.6604
2024-08-13 2022-12-31 13F ABBVIE COM 00287Y109 15,941 -38 -0.24 2,576 20.15 0.7034
2024-08-13 2022-09-30 13F ABBVIE COM 00287Y109 15,979 168 1.06 2,144 -11.44 0.6227
2024-08-13 2022-06-30 13F ABBVIE COM 00287Y109 15,811 204 1.31 2,422 -4.31 0.6570
2024-08-13 2022-03-31 13F ABBVIE COM 00287Y109 15,607 295 1.93 2,530 22.05 0.6607
2024-08-13 2021-12-31 13F ABBVIE COM 00287Y109 15,312 -245 -1.57 2,073 23.54 0.5393
2024-08-13 2021-09-30 13F ABBVIE COM 00287Y109 15,557 1,959 14.41 1,678 9.60 0.4855
2024-08-13 2021-06-30 13F ABBVIE COM 00287Y109 13,598 479 3.65 1,532 8.35 0.4759
2024-08-13 2021-03-31 13F ABBVIE COM 00287Y109 13,119 974 8.02 1,414 8.61 0.4935
2024-08-13 2020-12-31 13F ABBVIE COM 00287Y109 12,145 -94 -0.77 1,301 21.36 0.5121
2024-08-13 2020-09-30 13F ABBVIE COM 00287Y109 12,239 1,104 9.91 1,072 -1.92 0.4803
2024-08-13 2020-06-30 13F ABBVIE COM 00287Y109 11,135 3,281 41.77 1,093 82.78 0.5615
2024-08-13 2020-03-31 13F ABBVIE ABBVIE INC 00287Y109 7,854 3,763 91.98 598 65.19 0.4197
2024-08-13 2019-12-31 13F ABBVIE COM 00287Y109 4,091 352 9.41 362 27.92 0.1935
2024-08-13 2019-09-30 13F ABBVIE COM 00287Y109 3,739 -131 -3.39 283 0.71 0.1870
2024-08-13 2019-06-30 13F ABBVIE COM 00287Y109 3,870 353 10.04 281 -0.71 0.1925
2024-08-13 2019-03-31 13F ABBVIE COM 00287Y109 3,517 356 11.26 283 -2.75 0.2061
2024-08-13 2018-12-31 13F ABBVIE COM 00287Y109 3,161 30 0.96 291 -1.69 0.2455
2024-08-13 2018-09-30 13F ABBVIE COM 00287Y109 3,131 -170 -5.15 296 -2.95 0.2116
2024-08-13 2018-06-30 13F ABBVIE COM 00287Y109 3,301 241 7.88 306 5.54 0.2397
2024-08-14 2018-03-31 13F/A-1 ABBVIE ABBVIE INC 00287Y109 3,060 386 14.44 290 12.02 0.2391
2024-08-13 2018-03-31 13F ABBVIE COM 00287Y109 88,770 86,096 290 0.2391
2024-08-13 2017-12-31 13F ABBVIE COM 00287Y109 2,674 -174 -6.11 259 1.98 0.2249
2024-08-13 2017-09-30 13F ABBVIE COM 00287Y109 2,848 -24 -0.84 253 21.63 0.2364
2024-08-13 2017-06-30 13F ABBVIE COM 00287Y109 2,872 2 0.07 208 11.23 0.1665
2024-08-13 2017-03-31 13F ABBVIE COM 00287Y109 2,870 2 0.07 187 4.47 0.1608
2024-08-13 2016-12-31 13F ABBVIE COM 00287Y109 2,868 2,868 180 0.1619
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.